Valuation: CV Sciences, Inc.

Market Cap 4.9M 4.29M 3.96M 3.7M 6.96M 463M 7.11M 47.62M 18.38M 228M 18.38M 17.98M 793M P/E 2024
-2.48x
P/E 2025 -11.8x
Enterprise Value 6.61M 5.79M 5.35M 4.99M 9.4M 625M 9.61M 64.33M 24.83M 308M 24.84M 24.29M 1.07B EV / Sales 2024
0.42x
EV / Sales 2025 0.95x
Free-Float
92.21%
Yield 2024 *
-
Yield 2025 -
1 day-4.58%
1 week+1.78%
Current month-16.42%
1 month-16.42%
3 months-26.13%
6 months-54.65%
Current year-62.70%
1 week 0.02
Extreme 0.0203
0.03
1 month 0.02
Extreme 0.015
0.03
Current year 0.02
Extreme 0.015
0.1
1 year 0.02
Extreme 0.015
0.1
3 years 0.02
Extreme 0.015
0.1
5 years 0.02
Extreme 0.015
0.4
10 years 0.02
Extreme 0.015
9.2
Manager TitleAgeSince
Chief Executive Officer 68 2018-05-30
Director of Finance/CFO 51 2019-03-14
Director TitleAgeSince
Director/Board Member 68 2018-05-30
Director/Board Member 56 2022-07-20
Director/Board Member 58 2022-10-20
Date Insider Type Main position Quantity % Market Cap.
25-02-17Free

Chief Executive Officer

3,000,000 1.6281%
25-02-17Free

Chief Financial Officer

2,350,000 1.2753%
25-02-17Free

Director

500,000 0.2714%
Change 5-day change 1-year change 3-year change Capi.($)
-4.58%+1.78%-38.11%-46.62% 4.9M
+1.34%+10.63%+56.40%+162.48% 1,077B
+0.82%+10.82%+67.81%+56.20% 613B
+0.64%+10.47%+36.89%+90.72% 448B
+1.86%+4.85%+28.17%+22.04% 332B
-0.14%+7.58%+41.28%+27.25% 293B
-0.06%+4.92%+31.23%+41.59% 286B
-0.96%+4.98%-28.37%-40.96% 215B
+0.54%+4.38%+28.87%+62.70% 193B
-1.49%+0.82%+13.56%+65.64% 159B
Average -0.19%+9.63%+23.77%+44.10% 361.61B
Weighted average by Cap. +0.69%+9.65%+41.72%+80.49%

Financials

2024 2025
Net sales 15.7M 13.75M 12.69M 11.85M 22.32M 1.48B 22.82M 153M 58.98M 733M 58.98M 57.68M 2.54B 13.79M 12.07M 11.15M 10.41M 19.59M 1.3B 20.04M 134M 51.78M 643M 51.78M 50.65M 2.23B
Net income -2.39M -2.1M -1.94M -1.81M -3.4M -226M -3.48M -23.29M -8.99M -112M -8.99M -8.79M -388M -958K -839K -774K -723K -1.36M -90.57M -1.39M -9.32M -3.6M -44.68M -3.6M -3.52M -155M
Net Debt 325K 285K 263K 245K 462K 30.73M 472K 3.16M 1.22M 15.16M 1.22M 1.19M 52.63M 1.72M 1.5M 1.39M 1.3M 2.44M 162M 2.5M 16.71M 6.45M 80.13M 6.45M 6.31M 278M
Logo CV Sciences, Inc.
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.
Employees
43
Date Price Change Volume
26-06-29 US$0.0229 -4.58% 314,088
26-06-26 US$0.0240 +9.09% 1,840,006
26-06-25 US$0.0220 0.00% 1,634,141
26-06-24 US$0.0220 +5.90% 336,634
26-06-23 US$0.0208 -7.67% 862,510
  1. Stock Market
  2. Stocks
  3. CVSI Stock